Personalising glucose-lowering therapy in Type 2 Diabetes and CVD pati
- Cardio
- 21/03/2018
Type 2 diabetes mellitus (T2DM) is a complex disease with a pathogenesis that is multidimensional. Recently, several specific glucose-lowering agents have been demonstrated to improve cardiovascular...
READ MORE